에보진 (EVGN) 주가

에보진(EVGN)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.50 (-0.85%), 시가총액 $8.96M.

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products.

핵심 지표

• 현재가: $0.50 (-0.85%)
• 시가총액: $8.96M
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NAS

에보진의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

에보진 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 적극 매수 (5.0 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 6.18
• 순이익률: -220.22%

자주 묻는 질문